IPP Bureau
ICMR Dibrugarh designs kit to detect Omicron variant in two hours
By IPP Bureau - December 13, 2021
GCC Biotech is manufacturing the kits on a public-private partnership (PPP) model
Moderna announces positive interim Phase 1 data for mRNA flu vaccine
By IPP Bureau - December 13, 2021
Phase 1 study of quadrivalent flu vaccine (mRNA-1010) successfully boosted titers against all four strains in older and younger adults, even at lowest dose; no significant safety concerns were observed
Govt. to organise Innovation Week to encourage startup ecosystem
By IPP Bureau - December 13, 2021
The proposed week-long event will comprise specific themes - International engagements, market access and incubation support, funding support to startups etc. and will cover the different areas of the innovation lifecycle
Venky’s sets up plant to manufacture veterinary medicinal products
By IPP Bureau - December 13, 2021
The total cost of the project is estimated at Rs 30 crore
Zydus to begin Phase II (a) clinical trial of ZYIL1 in Australia
By IPP Bureau - December 13, 2021
It is a novel oral NLRP3 inflammasome inhibitor
Nova Nordisk to invest 17 bn Danish kroner to expand capacity in Denmark
By IPP Bureau - December 13, 2021
The investment will establish additional capacity across the entire global value chain from manufacturing of active pharmaceutical ingredients (API) to assembly and packaging, with the vast majority being invested in API capacity
Roche launches next-gen sample sequencing system
By IPP Bureau - December 13, 2021
Next-generation sequencing (NGS) enables a better understanding of genetic mechanisms linked to specific diseases and is helping drive personalised healthcare
Landbell and GreenForest solutions announce JV to reduce plastic waste
By IPP Bureau - December 13, 2021
The company will provide recyclability services to brands with a final goal to help them move to fully recyclable packaging
KOREA PACK and ICPI to be held in June 2022 in hybrid format
By IPP Bureau - December 13, 2021
KOREA PACK and concurrent event ICPI Week (Int’l Cosmetic and Pharmaceutical Industry Week) will be held as hybrid events in 2022
Philips instals 1000 active cath labs in India
By IPP Bureau - December 13, 2021
Over the next few years, Philips aims to double the number of its active cath labs in India with a special focus on improving accessibility to quality cardiac and neurovascular care in tier 2 and tier 3 cities
Zydus Pharmaceuticals USA receives tentative approval for schizophrenia drug
By IPP Bureau - December 11, 2021
The group now has 325 approvals and has so far filed over 400 ANDAs since the commencement of the filing process in FY 2003-04.
SPARC to present clinical data on vodobatinib
By IPP Bureau - December 11, 2021
Results from the ongoing vodobatinib clinical study are being presented for the second consecutive year at the ASH annual meeting, underlining the promising potential of the drug for the treatment of heavily pre-treated CML
Venus Remedies gets approval under the PLI scheme
By IPP Bureau - December 11, 2021
Under this scheme, the company will make a committed investment in plant and machinery, get incentives on incremental sales of pharmaceutical products
Cipla aims to improve access to nebulisers in PHCs
By IPP Bureau - December 11, 2021
The company will donate 5000 nebulizers to primary health care centres in rural India
Alembic acquires stake in RIGlmmune
By IPP Bureau - December 11, 2021
The company is focused on the development of novel treatments for RNA viruses
